Jefferies and Bank of China’s BOC International (“BOCI”) to Provide Joint Investment Banking and Capital Markets Services to Clients Globally
Jefferies LLC today announced that it has entered into a strategic alliance with BOC International Holdings Limited (“BOCI”), a wholly owned subsidiary of Bank of China. Under the agreement, BOCI and Jefferies will have the ability to jointly provide investment banking advisory and capital markets services to clients globally. In addition, BOCI and Jefferies will distribute co-branded equity research to their global base of institutional clients and will continue to provide sales and trading services to their clients with respect to the China and Hong Kong equity markets.
Benjamin Lorello, Global Head of Investment Banking at Jefferies, commented, “Our alliance with BOCI will allow us to better serve our clients in the US, Europe and Asia by providing unparalleled access to Chinese corporates and state owned enterprises through BOCI’s expansive footprint across China. Similarly, we will be able to better serve the strategic and capital markets needs of BOCI’s clients by providing access to Jefferies extensive network of corporate clients and to our capital markets capabilities across the U.S., Europe and the rest of Asia.”
“As part of Jefferies ongoing effort to meet the ever-changing needs of our global institutional clients, we are very pleased to begin working with BOCI. This alliance will strengthen our combined global investment banking and Pan-Asia equities businesses and strengthen our ability to provide our clients with market-leading ideas, strategies, execution and distribution,” added Michael Alexander, Chief Executive Officer of Jefferies Asia.
“We believe strongly in the value that this alliance will bring to our clients. The combination of local and global market insights will help us better serve clients’ sales and trading needs in the region,” commented Peter Forlenza, Global Head of Equities at Jefferies.
Wang Zhongze, Chief Financial Officer of BOCI, said, “At BOCI we are always committed to bring the best services to meet our clients’ requirements, and it is in our DNA to continuously seek innovative solutions for the interests of our clients. This collaboration will leverage both parties respective strengths in China and the other international financial markets to achieve a win-win-win for our clients, BOCI and Jefferies. The alliance with Jefferies is a perfect demonstration of our willingness to collaborate with other companies to give our clients the best-in-class products and services.”
Jefferies has 300 staff spread across the Asia region (150 people in head office in Hong Kong and 150 people in its offices in Tokyo, Singapore and Mumbai) and continues to build in the region.
Not including the firm’s research alliances, Jefferies’ global equity research business consists of 120 publishing analysts covering nearly 2,000 stocks from research centres in Frankfurt, London, Hong Kong, Mumbai, Singapore, Tokyo, Boston, Houston, Nashville, New York and San Francisco. The firm’s global coverage includes Economics & Strategy, Business Services, Consumer, Energy, Financial Services, Insurance, Healthcare, Industrials, Internet and Interactive Entertainment, Maritime, Media, Metals & Mining, MLPs, REITs, Technology, Telecommunications, Travel & Leisure and Utilities.
To learn more about Jefferies’ capabilities, please contact your Jefferies representative.
Jefferies, the world's only U.S.-headquartered independent full-service global investment banking firm focused on serving clients for over 50 years, is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, sales, trading, research and strategy across the spectrum of equities, fixed income and foreign exchange, as well as wealth management, in the Americas, Europe and Asia. Jefferies Group LLC is a wholly-owned subsidiary of Leucadia National Corporation (NYSE: LUK), a diversified holding company.
About BOC International
BOCI, one of the first investment banks established in China, is one of the biggest and strongest Chinese investment banks in overseas markets. BOCI has a leading position in the Hong Kong capital market in terms of overall competitiveness. Headquartered in Hong Kong with offices in Beijing, Shanghai, Shenzhen, London, New York and Singapore, BOCI provides clients with a full range of investment banking products and services in both mainland China and overseas capital markets, including share issuance, merger and acquisition, bond issuance, fixed-income, private banking, private equity, global commodities, asset management, equity derivatives, and leveraged and structured financing. It is one of the very few Chinese investment banks capable of providing international one-stop services in both the mainland China and Hong Kong markets. BOCI is a wholly-owned subsidiary of Bank of China (3988.HK; 601988.SS)
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Mavenir Wins 5G Asia “Best RAN Product” Award24.9.2018 13:00 | Pressemelding
Mavenir, focused on transforming mobile network economics for Communications Service Providers (CSPs), is proud to be awarded 5G Asia’s 2018 ‘Best RAN Product’ award for its innovative, flexible Cloud RAN solution. Mavenir’s Cloud RAN can save operators 37% in total cost of ownership (TCO) over a five-year period due to a 49% reduction in capex and a 31% annual reduction in opex1. The TechXLR8 5G Asia Awards were announced on September 19th in Singapore and celebrate excellence in the APAC’s technology and telecommunications community with the goal of showcasing the year’s greatest industry achievements. Mavenir’s Cloud RAN extends virtualization of the network to the edge and provides strategic differentiation by enabling the remote radio units (RRUs) to interwork with the virtualized cloud base band unit (vBBU) over ethernet fronthaul (FH) to the xRAN specification published early this year. Combined with network slicing support and flexibility for the vBBU to be co-located with the
ARTMS’ QUANTM Irradiation System™ to Be Featured at Two International Conferences in September24.9.2018 13:00 | Pressemelding
ARTMS Products, Inc. announced today that it has been invited to present at the National Nuclear Security Administration’s 2018 Mo-99 Topical Meeting on Tuesday, September 25th and the Third International Symposium on Technetium and other Radiometals in Chemistry and Medicine on Thursday, September 27th. Joel Kumlin will present at the 2018 Mo-99 Topical Meeting in Knoxville, TN, during Session 7, Production Projects and Technologies II, at 13:00EDT on September 25th. Mr. Kumlin will be discussing progress on implementation of the ARTMS QUANTM Irradiation System™ for producing technetium-99m. The QIS™ combines local production control and a cost-effective, easy-to-use solid target system for the production of Tc-99m on most cyclotron systems. ARTMS recently announced that the QIS™ received CE mark approval and has been installed in a number of countries throughout the world. ARTMS also announced that Dr. Paul Schaffer, CTO, has been invited to present at the Third International Symposi
Gilead Subsidiary to Launch Authorized Generics of Epclusa® (Sofosbuvir/Velpatasvir) and Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C24.9.2018 12:30 | Pressemelding
Gilead Sciences, Inc. (NASDAQ: GILD) announced today plans to launch authorized generic versions of Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni® (ledipasvir 90mg/sofosbuvir 400mg), Gilead’s leading treatments for chronic hepatitis C virus (HCV), in the United States, through a newly created subsidiary, Asegua Therapeutics LLC. The authorized generics will launch at a list price of $24,000 for the most common course of therapy and will be available in January 2019. Since the launch of Gilead’s first HCV medication in 2013, the average price paid for each bottle of medicine in the United States has decreased by more than 60 percent off of the public list prices, across health insurers and government payers. Due to the complexity and structure of the U.S. healthcare system, however, these discounts provided by Gilead may not always translate into lower costs for patients. Further, existing contracts, together with laws associated with government pricing policies, make it cha
GSMA To Showcase Mobile’s Increasing Impact on Sustainable Development During UN General Assembly Week24.9.2018 12:00 | Pressemelding
The GSMA will represent the global mobile industry at the 73rd session of the UN General Assembly (UNGA) being held in New York this week, advancing the leading role the sector is playing in meeting the UN Sustainable Development Goals (SDGs). Over the coming week, the GSMA will be participating in a wide range of activities with several high-profile partners and providing a critical platform for dialogue between mobile industry leaders, heads of state, global leaders and governments to further accelerate mobile’s contribution to the SDGs. “The GSMA will be in UNGA for the third year running to demonstrate how the global mobile industry is strengthening its commitment to improving lives around the world, as we enter a critical period in the delivery of the UN’s ambitious 2030 Agenda,” said Mats Granryd, Director General of the GSMA. “As the leading forum for international political cooperation, UNGA give us a unique opportunity to showcase how mobile’s unprecedented global scale is con
BolySolar Announcing Launch of BolySolar Tree24.9.2018 11:00 | Pressemelding
Bolymedia Holdings Co. Ltd., a global high-tech company headquartered in Silicon Valley, is pleased to announce its fifth patented renewable energy product – BolySolar Tree - at the Anaheim, California SPI to be held on September 24-27, 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005050/en/ BolySolar Tree (Graphic: Business Wire) BolySolar is a complete set of solar technologies and products that will revolutionize the entire energy industry. At SPI this month, the company will be showcasing its fifth product from its growing line of solar technologies - the BolySolar Tree. The diagram shows the basic design of the BolySolar Tree. The basic idea of the BolySolar Tree is to allow double-sided solar energy utilization with the help of mirrors, thereby reducing solar energy system costs and generating electricity for a longer duration. Compared to the conventional fixed-mount PV panel systems or tracker-mounted P
The 9th Edition of Tour of China 2018 Comes to an End24.9.2018 10:45 | Pressemelding
The sixteen-day Tour of China 2018 is concluded in Anshun, Guizhou Province on 23rd September, as the 13th stage witnesses the victory of Jakub Mareczko from Wilier Triestina – Selle Italia. The last stage in Anshun is a circuit race of 127.8 kilometers with two sprints and one KOM of Category 4. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005421/en/ The riders are crossing the finishing line. (Photo: Business Wire) The stage remained exciting and unpredictable due to little difference between riders’ results after the 12th stage. No rabbit group was formed even after 40 kilometers, though riders had never stopped breaking out from the peleton since race started. As the peleton kept its pace, Luke Mudgway from H&R Block Pro Cycling Team led the rabbit group of four who worked together quite well, with the gap of 1 minute 50 seconds. The gap narrowed, however, as the peleton started to chase with 30 kilometers to go,